スマートドラッグ＆ピル市場：ターゲット領域、タイプ、エンドユーザー、アプリケーション別-2025-2030年世界予測

スマートドラッグ＆ピル市場は、2023年に82億8,000万米ドルと評価され、2024年には101億8,000万米ドルに達すると予測され、CAGR 24.18％で成長し、2030年には377億1,000万米ドルに達すると予測されています。

スマートドラッグや錠剤は、しばしば向精神薬や認知増強剤として知られ、健康な人の認知機能、記憶力、創造性、意欲を向上させるように設計された物質です。精神的パフォーマンスを高め、長寿を促進することへの関心が高まるにつれ、市場の範囲は医薬品、栄養補助食品、機能性食品にまで拡大しています。その必要性は、職業環境における認知的要求の増大や、アルツハイマー病やADHDのような認知障害の有病率の上昇に起因しています。用途は幅広く、認知機能強化が高く評価されるヘルスケア、学術、軍事、企業部門に及んでいます。最終用途の範囲は、精神的な明晰さと生活の質の向上を求める学生、専門家、高齢者の間で特に広がっています。

市場成長は、バイオテクノロジーの進歩、認知サポートを求める高齢化人口の増加、メンタルヘルスとウェルネスに対する意識の高まりといった要因に影響されます。スマートドラッグへの容易なアクセスを提供するデジタル・プラットフォームの台頭も市場拡大を後押ししています。AIと機械学習を統合して認知機能強化ソリューションを個人のニーズに合わせてカスタマイズする個別化医療の開発には、注目すべき機会が存在します。しかし、市場の成長には、規制当局の監視、こうした医薬品の誤用や長期的な安全性に関する倫理的な議論、有効性や自然の代替品に関する消費者のさまざまな認識が課題となります。

革新のチャンスは、薬効や患者の健康をモニターするセンサーやワイヤレス接続を備えたスマートピルのようなドラッグデリバリーシステムを強化することにあります。テクノロジー企業と製薬会社のコラボレーションは、精密医療とデータ分析におけるブレークスルーを促し、ユーザーの転帰を向上させることができます。固有の課題はあるもの、認知機能改善に対する消費者の需要は高まり続けており、スマートドラッグ市場は大きく成長する見込みです。企業は、消費者の信頼を高めつつ規制状況に合わせるため、透明で倫理的なマーケティングと調査に投資することが推奨され、スマートドラッグは多面的な市場情勢の中で認知機能強化のための実行可能な選択肢となっています。

市場力学：急速に進化するスマートドラッグ＆ピル市場の主要市場洞察の解明

スマートドラッグ＆ピル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率上昇と相まって増加する老人人口
  • より良い診断のための低侵襲手術に対する患者の嗜好の高まり
  • 認知機能を高めるスマートドラッグ＆ピルの人気上昇
• 市場抑制要因
  • スマートドラッグ＆ピルに関連する高コスト
• 市場機会
  • スマートドラッグ＆ピルの継続的な技術進歩とイノベーション
  • スマートドラッグ＆ピル開発への研究開発投資の増加
• 市場の課題
  • スマートドラッグ＆ピルに関連する副作用

ポーターの5つの力：スマートドラッグ＆ピル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、スマートドラッグ＆ピル市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：スマートドラッグ＆ピル市場における外部からの影響の把握

外部マクロ環境要因は、スマートドラッグ＆ピル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析スマートドラッグ＆ピル市場における競合情勢の把握

スマートドラッグ＆ピル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックススマートドラッグ＆ピル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、スマートドラッグ＆ピル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨スマートドラッグ＆ピル市場における成功への道筋を描く

スマートドラッグ＆ピル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加と慢性疾患の罹患率の上昇
    • より良い診断のために低侵襲手術を好む患者が増えている
    • 認知機能を高めるスマートドラッグ＆ピルの人気上昇
  • 抑制要因
    • スマートドラッグ＆ピルに関連する高コスト
  • 機会
    • スマートドラッグ＆ピルにおける継続的な技術の進歩と革新
    • 研究開発投資の増加スマートドラッグ＆ピルの開発
  • 課題
    • スマートドラッグ＆ピルに関連する副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 スマートドラッグ＆ピル市場対象エリア別

• 食道
• 大腸
• 小腸
• 胃

第7章 スマートドラッグ＆ピル市場：タイプ別

• 市販の向知性薬
  • カフェイン
  • クレアチン
  • L-テアニン
  • オメガ3脂肪酸
  • ラセタム
• 処方箋不要の向知性薬

第8章 スマートドラッグ＆ピル市場：エンドユーザー別

• 診断センター
• 病院
• 調査機関

第9章 スマートドラッグ＆ピル市場：用途別

• カプセル内視鏡
• ドラッグデリバリー
• 患者モニタリング

第10章 南北アメリカのスマートドラッグ＆ピル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のスマートドラッグ＆ピル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのスマートドラッグ＆ピル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • BDとBIOCORP、自己投与注射薬の接続性とトレーサビリティを実現する契約を締結
  • AARDEX GroupがetectRxをMEMS接着ハードウェアエコシステムに追加
  • ハミルトンビーチ・ブランズ社とヘルスビーコン社が、スマートシャープスビン（TM）注射ケア管理システムの米国での発売を発表
  • AdhereTechは、スマート薬瓶、ソフトウェア、データ分析により服薬遵守率を向上させるためにAARDEXグループとの提携を発表
  • オリンパス、ハンブルクの新本社に移転-Olympus EMEA
  • スマートピルのスタートアップetectRxがPear Therapeuticsと提携
  • 「CapsoVision Inc.、 COVID-19流行中の在宅カプセル内視鏡検査CapsoCam Plusの投与に関するFDAの執行裁量を発表」
• 戦略分析と提言

企業一覧

• Aardex Group
• AnX Robotica Corp.
• CapsoVision, Inc.
• Check-Cap Ltd.
• GE Healthcare
• IntroMedic Co., Ltd.
• Jinshan Science & Technology（Group）Co., Ltd.
• Koninklijke Philips NV
• Medtronic PLC
• Novartis AG
• Olympus Corporation
• RF Co., Ltd.

LIST OF FIGURES

• FIGURE 1. SMART DRUGS & PILLS MARKET RESEARCH PROCESS
• FIGURE 2. SMART DRUGS & PILLS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SMART DRUGS & PILLS MARKET DYNAMICS
• TABLE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAFFEINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CREATINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY L-THEANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PRESCRIPTION NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 46. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 73. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 78. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 164. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 184. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 189. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023

The Smart Drugs & Pills Market was valued at USD 8.28 billion in 2023, expected to reach USD 10.18 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 37.71 billion by 2030.

Smart drugs and pills, often known as nootropics or cognitive enhancers, are substances designed to improve cognitive function, memory, creativity, or motivation in healthy individuals. With growing interest in enhancing mental performance and promoting longevity, the market scope has expanded to include pharmaceuticals, nutraceuticals, and functional foods. Their necessity stems from increasing cognitive demands in professional settings and the rising prevalence of cognitive impairments such as Alzheimer's and ADHD. Applications are widespread, spanning healthcare, academic, military, and corporate sectors where cognitive enhancement is highly valued. The end-use scope is particularly strong among students, professionals, and elderly populations seeking mental acuity and improved quality of life.

Market growth is influenced by factors such as advancements in biotechnology, a growing aging population seeking cognitive support, and heightened awareness about mental health and wellness. The rise of digital platforms offering easy access to smart drugs also fuels market expansion. Notable opportunities exist in the development of personalized medicine, integrating AI and machine learning to tailor cognitive enhancement solutions to individual needs. However, market growth is challenged by regulatory scrutiny, ethical debates about the misuse and long-term safety of such drugs, and variable consumer perceptions regarding efficacy and natural alternatives.

Innovation opportunities lie in enhancing drug delivery systems like smart pills with sensors and wireless connectivity to monitor drug efficacy and patient health. Collaborations between technology companies and pharmaceutical firms can spur breakthroughs in precision medicine and data analytics to enhance user outcomes. Despite the inherent challenges, the smart drug market is poised for considerable growth as consumer demand for cognitive improvement continues to rise. Companies are recommended to invest in transparent, ethical marketing and research to align with regulatory standards while amplifying consumer trust, making smart drugs a viable option for cognitive enhancement in a multifaceted market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Drugs & Pills Market

The Smart Drugs & Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population coupled with rising prevalence of chronic disorders
  • Increased patient preference for minimally invasive surgeries for better diagnosis
  • Rising popularity of smart drugs & pills to enhance cognitive functions
• Market Restraints
  • High cost associated with smart drugs & pills
• Market Opportunities
  • Ongoing technological advancements and innovations in smart drugs & pills
  • Increasing research and development investment in developing smart drugs & pills
• Market Challenges
  • Adverse reactions associated with smart drugs & pills

Porter's Five Forces: A Strategic Tool for Navigating the Smart Drugs & Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Drugs & Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Drugs & Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Drugs & Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Drugs & Pills Market

A detailed market share analysis in the Smart Drugs & Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Drugs & Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Drugs & Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Drugs & Pills Market

A strategic analysis of the Smart Drugs & Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Drugs & Pills Market, highlighting leading vendors and their innovative profiles. These include Aardex Group, AnX Robotica Corp., CapsoVision, Inc., Check-Cap Ltd., GE Healthcare, IntroMedic Co., Ltd., Jinshan Science & Technology (Group) Co., Ltd., Koninklijke Philips NV, Medtronic PLC, Novartis AG, Olympus Corporation, and RF Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Smart Drugs & Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Target Area, market is studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
• Based on Type, market is studied across Over-the-Counter Nootropics and Prescription Nootropics. The Over-the-Counter Nootropics is further studied across Caffeine, Creatine, L-theanine, Omega-3 fatty acids, and Racetams.
• Based on End User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
• Based on Application, market is studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population coupled with rising prevalence of chronic disorders
    • 5.1.1.2. Increased patient preference for minimally invasive surgeries for better diagnosis
    • 5.1.1.3. Rising popularity of smart drugs & pills to enhance cognitive functions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with smart drugs & pills
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological advancements and innovations in smart drugs & pills
    • 5.1.3.2. Increasing research and development investment in developing smart drugs & pills
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse reactions associated with smart drugs & pills
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Smart Drugs & Pills Market, by Target Area

• 6.1. Introduction
• 6.2. Esophagus
• 6.3. Large Intestine
• 6.4. Small Intestine
• 6.5. Stomach

7. Smart Drugs & Pills Market, by Type

• 7.1. Introduction
• 7.2. Over-the-Counter Nootropics
  • 7.2.1. Caffeine
  • 7.2.2. Creatine
  • 7.2.3. L-theanine
  • 7.2.4. Omega-3 fatty acids
  • 7.2.5. Racetams
• 7.3. Prescription Nootropics

8. Smart Drugs & Pills Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals
• 8.4. Research Institutes

9. Smart Drugs & Pills Market, by Application

• 9.1. Introduction
• 9.2. Capsule Endoscopy
• 9.3. Drug Delivery
• 9.4. Patient Monitoring

10. Americas Smart Drugs & Pills Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Smart Drugs & Pills Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Smart Drugs & Pills Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
  • 13.3.2. AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
  • 13.3.3. Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin(TM) Injection Care Management System
  • 13.3.4. AdhereTech Announces Partnership with AARDEX Group to Boost Medication Adherence with Smart Pill Bottle, Software and Data Analytics
  • 13.3.5. Olympus Moves into New Headquarters in Hamburg - Olympus EMEA
  • 13.3.6. Smart pill startup etectRx strikes partnership with Pear Therapeutics
  • 13.3.7. "CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19"
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aardex Group
• 2. AnX Robotica Corp.
• 3. CapsoVision, Inc.
• 4. Check-Cap Ltd.
• 5. GE Healthcare
• 6. IntroMedic Co., Ltd.
• 7. Jinshan Science & Technology (Group) Co., Ltd.
• 8. Koninklijke Philips NV
• 9. Medtronic PLC
• 10. Novartis AG
• 11. Olympus Corporation
• 12. RF Co., Ltd.